PDSB — PDS Biotechnology Share News
0.000.00%
Last trade - 00:00Brief: PDS Biotech To Be Added To Russell 2000 And Russell 3000 Indexes Effective June 26, 2023
U.S. STOCKS ON THE MOVE-Netflix, Nova Lifestyle, Nvidia
Brief: Netscientific Says PDS Biotechnology Announces Achievement Of Efficacy Threshold in Stage 2 of VERSATILE-002 Trial Evaluating PDS0101 and Keytruda
U.S. STOCKS ON THE MOVE-BlackRock, IPG Photonics, Estee Lauder
U.S. STOCKS ON THE MOVE-Amneal Pharma, 2seventy bio, Blue Water Biotech
Brief: PDS Biotechnology Announces Achievement Of Efficacy Threshold In Stage 2 Versatile-002 Trial
U.S. STOCKS ON THE MOVE-Advanced Micro Devices, NextDecade, Agile Therapeutics
PDS Biotech up as cancer therapy hits efficacy milestone in mid-stage study
Brief: PDS Biotechnology Announces Achievement Of Efficacy Threshold In Stage 2 Of Versatile-002 Trial Evaluating Pds0101 And Keytruda® In Head, Neck Cancer
U.S. STOCKS ON THE MOVE-Coherent, Copper miners, US banks
U.S. STOCKS ON THE MOVE-Ulta Beauty, Paramount Global, Microsoft
U.S. STOCKS ON THE MOVE-Marvell Technology, Tilray, Workday
PDS Biotech gains on positive interim cancer trial data for therapy combination
U.S. STOCKS ON THE MOVE-Ford Motor, Gap, Moderna
PDS Biotech up on positive interim cancer trial data for therapy combination
Brief: Pds Biotechnology Corp - Plans To Initiate Versatile-003 Phase 3 Clinical Trial In Late 2023
PDS Biotechnology Corp reports results for the quarter ended in March - Earnings Summary
Brief: PDS Biotech Provides Business Update And Reports First Quarter 2023 Financial Results
PDS Biotechnology Corp expected to post a loss of 31 cents a share - Earnings Preview